Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/6/2026

Treatment Algorithm for GERD Based on Symptom Severity

First-Line Treatment

  • The American Academy of Family Physicians recommends starting with lifestyle modifications plus proton pump inhibitors (PPIs) as first-line therapy for GERD, escalating to twice-daily dosing or adding adjunctive agents like alginate-antacids for breakthrough symptoms 1
  • PPIs are the most potent acid suppressants and superior to H2-receptor antagonists for controlling GERD symptoms and healing erosive esophagitis, according to the American Family Physician 2, 3, 1
  • The American College of Gastroenterology suggests starting with omeprazole 20 mg or lansoprazole 30 mg once daily, taken 30-60 minutes before the first meal 1
  • The guideline recommends using the lowest dose that controls symptoms, as there is no apparent dose-response relationship 1

Adjunctive Therapy for Breakthrough Symptoms

  • Alginate-antacids are superior to antacids alone and should be used for persistent post-prandial and nighttime breakthrough symptoms despite PPI therapy, as stated by the Praxis Medical Insights 1
  • The American Family Physician suggests using simple antacids like calcium carbonate (Tums), magnesium hydroxide (Milk of Magnesia), or aluminum hydroxide/magnesium hydroxide (Maalox, Mylanta) for rapid relief of sporadic, infrequent heartburn episodes only 2, 3
  • H2-receptor antagonists like ranitidine 150-300 mg twice daily or famotidine 20-40 mg twice daily can be added for nocturnal breakthrough symptoms despite PPI therapy, according to the BMJ and Praxis Medical Insights 4, 1, 5

Second-Line Treatment for Refractory Symptoms

  • If symptoms persist despite optimized PPI therapy, the Clinical Gastroenterology and Hepatology recommends proceeding with diagnostic testing and considering tricyclic antidepressants as neuromodulators 6, 1
  • The Gut journal suggests using amitriptyline starting at 10 mg at night, with slow titration by 10 mg weekly according to response and tolerability 7, 1

Third-Line: Surgical Intervention

  • Fundoplication should only be considered in carefully selected patients with objectively confirmed GERD who have failed optimized medical therapy, as stated by the American Family Physician and Clinical Gastroenterology and Hepatology 2, 3, 6
  • The Clinical Gastroenterology and Hepatology recommends performing shared decision-making before referral and requiring clear, objective evidence of GERD on diagnostic testing 6

Critical Pitfalls to Avoid

  • The American Family Physician advises against using metoclopramide as monotherapy or adjunctive therapy for GERD due to insufficient evidence and significant adverse effects 2, 3, 1
  • The Praxis Medical Insights recommends avoiding opioids in patients with severe or refractory dyspepsia to minimize iatrogenic harm 1
  • The American Family Physician suggests not relying solely on antacids if symptoms occur ≥2 times per week, as this requires stronger acid suppression 1, 8

Management of Amlodipine‑Induced Gastroesophageal Reflux

Identify and Address the Iatrogenic Cause

  • Calcium channel blockers such as amlodipine lower lower‑esophageal sphincter (LES) tone, making gastroesophageal reflux difficult to control even with aggressive acid suppression. 9
  • Switching from amlodipine to an alternative antihypertensive class (e.g., ACE inhibitor, ARB, or thiazide diuretic) can resolve reflux completely, often eliminating the need for long‑term acid‑suppression therapy. 9
  • Discontinuing or substituting amlodipine and initiating a once‑daily proton‑pump inhibitor (PPI) taken 30 minutes before breakfast is the recommended first‑line approach. 9

Pharmacologic Acid Suppression

  • PPIs are the most potent acid suppressants and are superior to H₂‑receptor antagonists for both symptom control and healing of erosive esophagitis in GERD. 10
  • H₂‑receptor antagonists provide only 40–60 % symptomatic improvement in erosive disease, develop tachyphylaxis within ~6 weeks, and are therefore less effective than PPIs for moderate‑to‑severe GERD. 10
  • Routine use of the prokinetic metoclopramide is not recommended because its adverse‑effect profile (drowsiness, restlessness, extrapyramidal reactions) outweighs benefits, and evidence supporting its efficacy in GERD is insufficient. 10

Optimal PPI Administration Timing

  • PPIs should be taken before meals—ideally 30 minutes prior—to align with post‑prandial activation of gastric proton pumps and achieve maximal acid suppression. 11

Lifestyle Modifications (Adjunctive Measures)

  • An antireflux diet limiting total daily fat intake to <45 g and avoiding coffee, tea, soda, chocolate, mint, citrus (including tomatoes), and alcohol helps reduce reflux episodes. 9
  • Patients should refrain from eating within 3 hours of bedtime to minimize nocturnal reflux. 9
  • Smoking cessation is essential for optimal reflux control. 9

Therapeutic Pitfalls to Avoid

  • Escalating acid‑suppression therapy without first addressing the amlodipine exposure is ineffective, because the calcium‑channel blocker continues to mechanically worsen reflux regardless of acid control. 9

All facts are derived from peer‑reviewed sources and reflect current evidence‑based recommendations.